2020. Comparison of Safety and Economic Burden of Dipeptidyl Peptidase-4-Inhibitor Versus Sulfonylureas in Type 2 Diabetes Patients Inadequately Controlled with Metformin; A Narrative Review. Indian Journal of Public Health Research & Development. 11, 7 (Jul. 2020), 1063–1069. DOI:https://doi.org/10.37506/ijphrd.v11i7.10232.